Short answer
agilon health, inc. (AGL) filed its Q3 2025 10-Q quarterly report on Nov 4, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.4B (down 1.1% year over year) with net income of −$110M.
Q3 2025 key financials · XBRL
- Revenue
- $1.4B
- −1.1% YoY · +2.9% QoQ
- Net income
- −$110M
- +6.3% YoY · −5.6% QoQ
- Operating margin
- -9.1%
Source: XBRL data from the agilon health, inc. (AGL) Q3 2025 10-Q on SEC EDGAR. USD.
agilon health, inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Headwinds: medical expenses, membership reductions, payor dependence, healthcare regulation, and capital availability
- Outlook: management transition risk, including search for a permanent Chief Executive Officer
Risk Factors
- No material risk-factor changes from the December 31, 2024 Form 10-K
- Carried-forward regulatory, legal, operational, competitive, and financial risks remain applicable
- September 4, 2025 separation agreement with Steven Sell disclosed in exhibits
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other agilon health, inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.